Bristol Gives Up On Adjuvant Melanoma For Opdualag With Failed Trial

 
• By Joseph Haas
  
Bristol Myers Squibb fails a Phase III study with Opdualag in adjuvant melanoma • Source: Shutterstock

More from Clinical Trials

More from Therapy Areas